Market Research Logo

Biotechnology in Belgium

Introduction

Biotechnology in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The Belgian biotechnology industry had total revenues of $7.8bn in 2014, representing a compound annual growth rate (CAGR) of 7% between 2010 and 2014.
  • The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $6.0bn, equivalent to 76.4% of the industry's overall value.
  • The performance of the industry is forecast to accelerate, with an anticipated CAGR of 8.8% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $11.9bn by the end of 2019.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in Belgium

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Belgium

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Belgium biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Belgium economy

Key Questions Answered

What was the size of the Belgium biotechnology market by value in 2014?

What will be the size of the Belgium biotechnology market in 2019?

What factors are affecting the strength of competition in the Belgium biotechnology market?

How has the market performed over the last five years?


Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
AstraZeneca PLC
Novartis AG
Sanofi SA
ThromboGenics NV
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
LIST OF TABLES
Table 1: Belgium biotechnology industry value: $ billion, 2010–14(e)
Table 2: Belgium biotechnology industry category segmentation: $ billion, 2014(e)
Table 3: Belgium biotechnology industry geography segmentation: $ billion, 2014(e)
Table 4: Belgium biotechnology industry value forecast: $ billion, 2014–19
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Novartis AG: key facts
Table 9: Novartis AG: key financials ($)
Table 10: Novartis AG: key financial ratios
Table 11: Sanofi SA: key facts
Table 12: Sanofi SA: key financials ($)
Table 13: Sanofi SA: key financials (€)
Table 14: Sanofi SA: key financial ratios
Table 15: ThromboGenics NV: key facts
Table 16: ThromboGenics NV: key financials ($)
Table 17: ThromboGenics NV: key financials (€)
Table 18: ThromboGenics NV: key financial ratios
Table 19: Belgium size of population (million), 2010–14
Table 20: Belgium gdp (constant 2005 prices, $ billion), 2010–14
Table 21: Belgium gdp (current prices, $ billion), 2010–14
Table 22: Belgium inflation, 2010–14
Table 23: Belgium consumer price index (absolute), 2010–14
Table 24: Belgium exchange rate, 2010–14
LIST OF FIGURES
Figure 1: Belgium biotechnology industry value: $ billion, 2010–14(e)
Figure 2: Belgium biotechnology industry category segmentation: % share, by value, 2014(e)
Figure 3: Belgium biotechnology industry geography segmentation: % share, by value, 2014(e)
Figure 4: Belgium biotechnology industry value forecast: $ billion, 2014–19
Figure 5: Forces driving competition in the biotechnology industry in Belgium, 2014
Figure 6: Drivers of buyer power in the biotechnology industry in Belgium, 2014
Figure 7: Drivers of supplier power in the biotechnology industry in Belgium, 2014
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Belgium, 2014
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Belgium, 2014
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Belgium, 2014
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: Sanofi SA: revenues & profitability
Figure 16: Sanofi SA: assets & liabilities
Figure 17: ThromboGenics NV: revenues & profitability
Figure 18: ThromboGenics NV: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report